A multicountry pooled analysis shows that treatment success rates for extensively drug-resistant tuberculosis are extremely ...

Your healthcare provider may also recommend a TB test — either a blood test or a skin test. For the skin test, you will need ...

In Germany, it is often overlooked that diseases once thought to be defeated, like tuberculosis, still exist and that the ...

A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling ...

High-dose rifampicin may clear TB bacteria faster, but risks like liver injury above 30 mg/kg need caution. Larger trials are ...

A recent phase 2b clinical trial in South Africa found that Bacille Calmette-Guérin (BCG) revaccination did not prevent ...

TB infection is different from active TB disease; and a flare up could happen within weeks of acquiring the infection or maybe years ...

Tuberculosis (TB) belongs to infectious diseases leading to the high mortality and morbidity worldwide. Since long-term ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

Tuberculosis remains a major health challenge in South Africa, but professional nurse Nhlanhla Mofokeng is determined to ...

Tuberculosis is the world's deadliest infectious disease, but Queensland researchers think more effective protection could be ...